Replies to post #9001 on Biotech Values

[si39]

Doing business with EMEA seems to be a black hole.
GTCB's Cox said they have more q, but don't talk about whether GTCB has received the q.
Maybe another trial.

[Biowatch]

Could you hear any of the Q&A this AM on GTCB talk?

[Aiming4]

Wow. That's a serious chunk of GTCB.

But... I'm considering a similar move, albeit not quite on that scale. :^)

My 100% unscientific thought is that prices might be a little lower this afternoon as some laggards react to the news and sell, plus others may sell going into the weekend so they can re-evaluate GTCB.

Every penny saved today is roughly an extra 1% of GTCB my money will buy... Aiming4.

[randychub]

Whats the hurry. These things usually take a few days/weeks to shake out.

R

[EZ2]

I would prefer.....................

Call me crazy…

"Call me brilliant" !!!!!!!!!!!!!!!

[urche]

Re: Call me crazy…

Some might call me lucky.

Here's a trading anecdote. I placed several GTCB sell orders last night at prices from 1.62 to 1.79. By luck, Vanguard sold a chunk for me at 1.63, the high for the day. I then repurchased the same shares at 1.25 a few minutes later, a few pennies above the low for the day. I am not a day trader, but that was pretty darn fun....until I realized how many thousands of dollars I lost today overall.

DEW, FWIW, I think the chances of EMEA requesting a new study are <25%. But, I think there is higher chance that some EMEA commisioners want to know how soon the US ATryn could be completed and are going to ask for feasibility or outright demand that approval be deferred until after that study.

So, I fear GTCB is dead money for a number of months.

Urche